ClinicalTrials.govpublic full text
PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma
diffuse midline glioma, diffuse midline high-grade glioma, medulloblastoma, ependymoma
ClinicalTrials.gov
Show glossary
Search for terms
Hide glossary
Study record managers: refer to the
Data Element Definitions
if submitting registration or results information.
Record · ID 18724 · SHA-256 17c3746fc8cd5ac2
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.